211 related articles for article (PubMed ID: 34903602)
1. PKM2 Is Essential for Bladder Cancer Growth and Maintenance.
Xia Y; Wang X; Liu Y; Shapiro E; Lepor H; Tang MS; Sun TT; Wu XR
Cancer Res; 2022 Feb; 82(4):571-585. PubMed ID: 34903602
[TBL] [Abstract][Full Text] [Related]
2. Maintenance of the bladder cancer precursor urothelial hyperplasia requires FOXA1 and persistent expression of oncogenic HRAS.
Yee CH; Zheng Z; Shuman L; Yamashita H; Warrick JI; Wu XR; Raman JD; DeGraff DJ
Sci Rep; 2019 Jan; 9(1):270. PubMed ID: 30670749
[TBL] [Abstract][Full Text] [Related]
3. Role of isoenzyme M2 of pyruvate kinase in urothelial tumorigenesis.
Zhou H; Wang X; Mo L; Liu Y; He F; Zhang F; Huang KH; Wu XR
Oncotarget; 2016 Apr; 7(17):23947-60. PubMed ID: 26992222
[TBL] [Abstract][Full Text] [Related]
4. Alteration of the vascular endothelial growth factor and angiopoietins-1 and -2 pathways in transitional cell carcinomas of the urinary bladder associated with tumor progression.
Quentin T; Schlott T; Korabiowska M; Käthei N; Zöller G; Glaser F; Kunze E
Anticancer Res; 2004; 24(5A):2745-56. PubMed ID: 15517881
[TBL] [Abstract][Full Text] [Related]
5. Loss of p53 and acquisition of angiogenic microRNA profile are insufficient to facilitate progression of bladder urothelial carcinoma in situ to invasive carcinoma.
Ayala de la Peña F; Kanasaki K; Kanasaki M; Tangirala N; Maeda G; Kalluri R
J Biol Chem; 2011 Jun; 286(23):20778-87. PubMed ID: 21388952
[TBL] [Abstract][Full Text] [Related]
6. Pyruvate kinase M2 affects liver cancer cell behavior through up-regulation of HIF-1α and Bcl-xL in culture.
Dong T; Yan Y; Chai H; Chen S; Xiong X; Sun D; Yu Y; Deng L; Cheng F
Biomed Pharmacother; 2015 Feb; 69():277-84. PubMed ID: 25661370
[TBL] [Abstract][Full Text] [Related]
7. Pyruvate kinase M2 inhibits the progression of bladder cancer by targeting MAKP pathway.
Zhu Q; Hong B; Zhang L; Wang J
J Cancer Res Ther; 2018 Sep; 14(Supplement):S616-S621. PubMed ID: 30249877
[TBL] [Abstract][Full Text] [Related]
8. PKM2 promotes tumor angiogenesis by regulating HIF-1α through NF-κB activation.
Azoitei N; Becher A; Steinestel K; Rouhi A; Diepold K; Genze F; Simmet T; Seufferlein T
Mol Cancer; 2016 Jan; 15():3. PubMed ID: 26739387
[TBL] [Abstract][Full Text] [Related]
9. HRAS as a potential therapeutic target of salirasib RAS inhibitor in bladder cancer.
Sugita S; Enokida H; Yoshino H; Miyamoto K; Yonemori M; Sakaguchi T; Osako Y; Nakagawa M
Int J Oncol; 2018 Aug; 53(2):725-736. PubMed ID: 29901113
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-driven osteopontin contributes to breast tumor growth through modulation of HIF1α-mediated VEGF-dependent angiogenesis.
Raja R; Kale S; Thorat D; Soundararajan G; Lohite K; Mane A; Karnik S; Kundu GC
Oncogene; 2014 Apr; 33(16):2053-64. PubMed ID: 23728336
[TBL] [Abstract][Full Text] [Related]
11. Pyruvate kinase expression (PKM1 and PKM2) in cancer-associated fibroblasts drives stromal nutrient production and tumor growth.
Chiavarina B; Whitaker-Menezes D; Martinez-Outschoorn UE; Witkiewicz AK; Birbe R; Howell A; Pestell RG; Smith J; Daniel R; Sotgia F; Lisanti MP
Cancer Biol Ther; 2011 Dec; 12(12):1101-13. PubMed ID: 22236875
[TBL] [Abstract][Full Text] [Related]
12. Signal transducer and activator of transcription 3 promotes the Warburg effect possibly by inducing pyruvate kinase M2 phosphorylation in liver precancerous lesions.
Bi YH; Han WQ; Li RF; Wang YJ; Du ZS; Wang XJ; Jiang Y
World J Gastroenterol; 2019 Apr; 25(16):1936-1949. PubMed ID: 31086462
[TBL] [Abstract][Full Text] [Related]
13. Effects of YC-1 on hypoxia-inducible factor 1 alpha in hypoxic human bladder transitional carcinoma cell line T24 cells.
Li Y; Zhao X; Tang H; Zhong Z; Zhang L; Xu R; Li S; Wang Y
Urol Int; 2012; 88(1):95-101. PubMed ID: 22041818
[TBL] [Abstract][Full Text] [Related]
14. Antiangiogenic activity of phthalides-enriched Angelica Sinensis extract by suppressing WSB-1/pVHL/HIF-1α/VEGF signaling in bladder cancer.
Chen MC; Hsu WL; Chang WL; Chou TC
Sci Rep; 2017 Jul; 7(1):5376. PubMed ID: 28710377
[TBL] [Abstract][Full Text] [Related]
15. Pyruvate kinase M2 facilitates colon cancer cell migration via the modulation of STAT3 signalling.
Yang P; Li Z; Fu R; Wu H; Li Z
Cell Signal; 2014 Sep; 26(9):1853-62. PubMed ID: 24686087
[TBL] [Abstract][Full Text] [Related]
16. Glucose Catabolism in Liver Tumors Induced by c-MYC Can Be Sustained by Various PKM1/PKM2 Ratios and Pyruvate Kinase Activities.
Méndez-Lucas A; Li X; Hu J; Che L; Song X; Jia J; Wang J; Xie C; Driscoll PC; Tschaharganeh DF; Calvisi DF; Yuneva M; Chen X
Cancer Res; 2017 Aug; 77(16):4355-4364. PubMed ID: 28630053
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-inducible factor-1alpha expression correlates with focal macrophage infiltration, angiogenesis and unfavourable prognosis in urothelial carcinoma.
Chai CY; Chen WT; Hung WC; Kang WY; Huang YC; Su YC; Yang CH
J Clin Pathol; 2008 May; 61(5):658-64. PubMed ID: 17908805
[TBL] [Abstract][Full Text] [Related]
18. The role of the HIF-1α/ALYREF/PKM2 axis in glycolysis and tumorigenesis of bladder cancer.
Wang JZ; Zhu W; Han J; Yang X; Zhou R; Lu HC; Yu H; Yuan WB; Li PC; Tao J; Lu Q; Wei JF; Yang H
Cancer Commun (Lond); 2021 Jul; 41(7):560-575. PubMed ID: 33991457
[TBL] [Abstract][Full Text] [Related]
19. Heme oxygenase-1 promotes angiogenesis in urothelial carcinoma of the urinary bladder.
Miyake M; Fujimoto K; Anai S; Ohnishi S; Kuwada M; Nakai Y; Inoue T; Matsumura Y; Tomioka A; Ikeda T; Tanaka N; Hirao Y
Oncol Rep; 2011 Mar; 25(3):653-60. PubMed ID: 21206978
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-204 deregulation in lung adenocarcinoma controls the biological behaviors of endothelial cells potentially by modulating Janus kinase 2-signal transducer and activator of transcription 3 pathway.
Liu X; Gao X; Zhang W; Zhu T; Bi W; Zhang Y
IUBMB Life; 2018 Jan; 70(1):81-91. PubMed ID: 29281186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
